

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.84498718 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.84498718 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.84498718 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.84498718 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.84498718 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.84498718 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.55328425 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.44249355 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.33596265 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.33596265 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 5.51557039 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.22854699 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 5.17576446 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 5.00597119 |
| 15 | positive regulation of antigen processing and presentation (GO:0002579) | 4.98662296 |
| 16 | respiratory burst (GO:0045730) | 4.94566788 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.91872602 |
| 18 | glycolipid catabolic process (GO:0019377) | 4.89971553 |
| 19 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.83151623 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 4.81773977 |
| 21 | oligosaccharide catabolic process (GO:0009313) | 4.77305022 |
| 22 | microglial cell activation (GO:0001774) | 4.76737930 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.72701675 |
| 24 | type I interferon signaling pathway (GO:0060337) | 4.63350657 |
| 25 | cellular response to type I interferon (GO:0071357) | 4.63350657 |
| 26 | response to type I interferon (GO:0034340) | 4.58506849 |
| 27 | response to peptidoglycan (GO:0032494) | 4.51735491 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.49611021 |
| 29 | response to host immune response (GO:0052572) | 4.49611021 |
| 30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.47133246 |
| 31 | amino sugar catabolic process (GO:0046348) | 4.40612236 |
| 32 | regulation of antigen processing and presentation (GO:0002577) | 4.36073804 |
| 33 | ceramide catabolic process (GO:0046514) | 4.35358710 |
| 34 | cellular extravasation (GO:0045123) | 4.30422759 |
| 35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.24946222 |
| 36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.20590585 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.16510873 |
| 38 | regulation of macrophage chemotaxis (GO:0010758) | 4.15012397 |
| 39 | cellular response to interferon-beta (GO:0035458) | 4.14614044 |
| 40 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.11270154 |
| 41 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.10811383 |
| 42 | natural killer cell mediated immunity (GO:0002228) | 4.10811383 |
| 43 | positive regulation of interferon-beta production (GO:0032728) | 4.03485183 |
| 44 | response to host (GO:0075136) | 3.99394469 |
| 45 | response to host defenses (GO:0052200) | 3.99394469 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.99394469 |
| 47 | defense response to protozoan (GO:0042832) | 3.93672665 |
| 48 | macrophage activation (GO:0042116) | 3.86052236 |
| 49 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.84240526 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.81610847 |
| 51 | response to thyroid hormone (GO:0097066) | 3.79323580 |
| 52 | cellular response to exogenous dsRNA (GO:0071360) | 3.78085916 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.77352358 |
| 54 | barbed-end actin filament capping (GO:0051016) | 3.73060266 |
| 55 | positive regulation of mast cell degranulation (GO:0043306) | 3.69656623 |
| 56 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.69656623 |
| 57 | response to interferon-beta (GO:0035456) | 3.69123890 |
| 58 | membrane lipid catabolic process (GO:0046466) | 3.61579096 |
| 59 | reactive oxygen species biosynthetic process (GO:1903409) | 3.61075868 |
| 60 | B cell mediated immunity (GO:0019724) | 3.58006390 |
| 61 | cellular response to interferon-gamma (GO:0071346) | 3.53389028 |
| 62 | apoptotic cell clearance (GO:0043277) | 3.52976169 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.50026613 |
| 64 | sphingolipid catabolic process (GO:0030149) | 3.48933607 |
| 65 | positive regulation of leukocyte degranulation (GO:0043302) | 3.48674615 |
| 66 | regulation of chemokine biosynthetic process (GO:0045073) | 3.47467902 |
| 67 | superoxide anion generation (GO:0042554) | 3.47174826 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 3.45165305 |
| 69 | eosinophil migration (GO:0072677) | 3.45005082 |
| 70 | response to interferon-alpha (GO:0035455) | 3.42223226 |
| 71 | phagosome maturation (GO:0090382) | 3.42109536 |
| 72 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42077179 |
| 73 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.41296942 |
| 74 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.39194841 |
| 75 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.38813621 |
| 76 | macrophage differentiation (GO:0030225) | 3.37528549 |
| 77 | regulation of mononuclear cell migration (GO:0071675) | 3.35471392 |
| 78 | myeloid dendritic cell differentiation (GO:0043011) | 3.35434955 |
| 79 | negative regulation of viral genome replication (GO:0045071) | 3.35020246 |
| 80 | cellular response to cadmium ion (GO:0071276) | 3.34617766 |
| 81 | granulocyte activation (GO:0036230) | 3.32185389 |
| 82 | response to protozoan (GO:0001562) | 3.31499118 |
| 83 | response to interferon-gamma (GO:0034341) | 3.26768943 |
| 84 | lymphocyte chemotaxis (GO:0048247) | 3.26590941 |
| 85 | negative regulation of mast cell activation (GO:0033004) | 3.24672030 |
| 86 | N-acetylneuraminate metabolic process (GO:0006054) | 3.23884651 |
| 87 | negative regulation of cell killing (GO:0031342) | 3.22260005 |
| 88 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.22260005 |
| 89 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.21748946 |
| 90 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.21388505 |
| 91 | peptide catabolic process (GO:0043171) | 3.19129204 |
| 92 | response to muramyl dipeptide (GO:0032495) | 3.17274774 |
| 93 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.16920234 |
| 94 | adhesion of symbiont to host cell (GO:0044650) | 3.15900142 |
| 95 | virion attachment to host cell (GO:0019062) | 3.15900142 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15766974 |
| 97 | cellular response to interferon-alpha (GO:0035457) | 3.13751569 |
| 98 | detection of molecule of bacterial origin (GO:0032490) | 3.12390436 |
| 99 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.11719458 |
| 100 | eosinophil chemotaxis (GO:0048245) | 3.09630670 |
| 101 | positive regulation of type 2 immune response (GO:0002830) | 3.09372036 |
| 102 | detection of other organism (GO:0098543) | 3.08996202 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 3.08801224 |
| 104 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.08494936 |
| 105 | regulation of monocyte chemotaxis (GO:0090025) | 3.08134982 |
| 106 | T-helper 1 type immune response (GO:0042088) | 3.08002165 |
| 107 | lymphocyte mediated immunity (GO:0002449) | 3.07850660 |
| 108 | neutrophil activation (GO:0042119) | 3.07726701 |
| 109 | * intracellular pH reduction (GO:0051452) | 3.06923194 |
| 110 | regulation of hypersensitivity (GO:0002883) | 3.06372611 |
| 111 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.05858507 |
| 112 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05259941 |
| 113 | myeloid dendritic cell activation (GO:0001773) | 3.03379928 |
| 114 | leukocyte mediated cytotoxicity (GO:0001909) | 3.03070002 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 3.02561873 |
| 116 | monocyte chemotaxis (GO:0002548) | 3.01211704 |
| 117 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.00989927 |
| 118 | glycosphingolipid catabolic process (GO:0046479) | 2.99707401 |
| 119 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.99440402 |
| 120 | regulation of mast cell degranulation (GO:0043304) | 2.99005216 |
| 121 | T cell migration (GO:0072678) | 2.97452979 |
| 122 | positive regulation of interleukin-12 production (GO:0032735) | 2.96108986 |
| 123 | regulation of cholesterol storage (GO:0010885) | 2.96096173 |
| 124 | detection of external biotic stimulus (GO:0098581) | 2.95310038 |
| 125 | positive regulation of macrophage cytokine production (GO:0060907) | 2.95269771 |
| 126 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93674553 |
| 127 | NIK/NF-kappaB signaling (GO:0038061) | 2.92563036 |
| 128 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92274395 |
| 129 | pinocytosis (GO:0006907) | 2.89519023 |
| 130 | I-kappaB phosphorylation (GO:0007252) | 2.88965591 |
| 131 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.87948473 |
| 132 | regulation of interferon-beta production (GO:0032648) | 2.87293145 |
| 133 | defense response to virus (GO:0051607) | 2.86519936 |
| 134 | myeloid leukocyte activation (GO:0002274) | 2.86279371 |
| 135 | granulocyte chemotaxis (GO:0071621) | 2.85610114 |
| 136 | regulation of T cell tolerance induction (GO:0002664) | 2.84967319 |
| 137 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.84866003 |
| 138 | detection of bacterium (GO:0016045) | 2.84511391 |
| 139 | regulation of mast cell activation (GO:0033003) | 2.83932479 |
| 140 | dendritic cell differentiation (GO:0097028) | 2.82706706 |
| 141 | regulation of superoxide anion generation (GO:0032928) | 2.82640333 |
| 142 | cellular response to zinc ion (GO:0071294) | 2.82103716 |
| 143 | positive regulation of mast cell activation (GO:0033005) | 2.81255646 |
| 144 | regulation of gamma-delta T cell activation (GO:0046643) | 2.80507241 |
| 145 | neutrophil chemotaxis (GO:0030593) | 2.80488747 |
| 146 | germinal center formation (GO:0002467) | 2.79659593 |
| 147 | regulation of podosome assembly (GO:0071801) | 2.76055400 |
| 148 | adhesion of symbiont to host (GO:0044406) | 2.75011803 |
| 149 | granulocyte migration (GO:0097530) | 2.73774390 |
| 150 | neutrophil migration (GO:1990266) | 2.73069266 |
| 151 | angiotensin maturation (GO:0002003) | 2.72915965 |
| 152 | positive regulation of bone remodeling (GO:0046852) | 2.71959880 |
| 153 | positive regulation of bone resorption (GO:0045780) | 2.71959880 |
| 154 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70412111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.26832977 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 8.04038760 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.90923592 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.80619629 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.87820851 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.74679884 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.04893920 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66398968 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.61930045 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.02332142 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94311280 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.76284621 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54168696 |
| 14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53465131 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48529955 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44817993 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41678680 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40315215 |
| 19 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26585155 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97788535 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93653159 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.92881629 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.81052511 |
| 24 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79349889 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77297226 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75907500 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75054243 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72678962 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72008353 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65019621 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61876835 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56364179 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.55635072 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53009209 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52297834 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50379658 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49202793 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47514827 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44372186 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.36568356 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32665317 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29675734 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29151058 |
| 44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27702152 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.24377320 |
| 46 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21164899 |
| 47 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20011178 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18069809 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17224508 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16193426 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14903627 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14308157 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10410245 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09619813 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09508893 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08244536 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07695813 |
| 58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07305302 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.06624696 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06252116 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05696389 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03679241 |
| 63 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03525242 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03458265 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02161482 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01177331 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01075575 |
| 68 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99796173 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99637118 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99591433 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98434625 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97807250 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97046326 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95991277 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95788540 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94066695 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93285405 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93188892 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91489844 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91168378 |
| 81 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91027103 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90353043 |
| 83 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90329594 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88220799 |
| 85 | MYC_22102868_ChIP-Seq_BL_Human | 0.87470587 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87341231 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87341231 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85628447 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84203028 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81153255 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.78759690 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.77974098 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.77616405 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77608301 |
| 95 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.76525634 |
| 96 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76090596 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75896575 |
| 98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74469481 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72611390 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72234608 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68828900 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 0.68732667 |
| 103 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.68649253 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68462777 |
| 105 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.68374509 |
| 106 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.67709728 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.67496866 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67285258 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64968854 |
| 110 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.64407443 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.63125375 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62138921 |
| 113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62053375 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.61733623 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.61273388 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60702138 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60531141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.13127798 |
| 2 | MP0006082_CNS_inflammation | 4.03702842 |
| 3 | MP0004510_myositis | 3.84478151 |
| 4 | MP0003303_peritoneal_inflammation | 3.72142074 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.67013820 |
| 6 | MP0009785_altered_susceptibility_to | 3.57609888 |
| 7 | MP0003436_decreased_susceptibility_to | 3.50270382 |
| 8 | MP0002419_abnormal_innate_immunity | 3.11495881 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 3.01886615 |
| 10 | MP0005025_abnormal_response_to | 3.01864635 |
| 11 | MP0005387_immune_system_phenotype | 2.93590730 |
| 12 | MP0001790_abnormal_immune_system | 2.93590730 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.91635300 |
| 14 | MP0005671_abnormal_response_to | 2.69179388 |
| 15 | MP0003724_increased_susceptibility_to | 2.69109219 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.64181310 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.58630695 |
| 18 | MP0000685_abnormal_immune_system | 2.52274367 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.48080525 |
| 20 | MP0001800_abnormal_humoral_immune | 2.36757093 |
| 21 | MP0002723_abnormal_immune_serum | 2.33102150 |
| 22 | MP0001853_heart_inflammation | 2.13242659 |
| 23 | MP0004947_skin_inflammation | 2.13110952 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.12572664 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.10557462 |
| 26 | MP0001819_abnormal_immune_cell | 2.10138461 |
| 27 | MP0002420_abnormal_adaptive_immunity | 2.03133863 |
| 28 | MP0000604_amyloidosis | 1.99070940 |
| 29 | MP0003075_altered_response_to | 1.98450465 |
| 30 | MP0003448_altered_tumor_morphology | 1.98040119 |
| 31 | MP0000343_altered_response_to | 1.93679306 |
| 32 | MP0004858_abnormal_nervous_system | 1.85191438 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.83404878 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.81567810 |
| 35 | MP0003690_abnormal_glial_cell | 1.75799927 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.73451743 |
| 37 | MP0009764_decreased_sensitivity_to | 1.67978956 |
| 38 | MP0009840_abnormal_foam_cell | 1.66456819 |
| 39 | MP0005310_abnormal_salivary_gland | 1.64184961 |
| 40 | MP0008469_abnormal_protein_level | 1.63905337 |
| 41 | MP0002405_respiratory_system_inflammati | 1.62165327 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.60823402 |
| 43 | MP0005166_decreased_susceptibility_to | 1.51620481 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.48447240 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.48336462 |
| 46 | MP0000716_abnormal_immune_system | 1.42899783 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.39135555 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.38346601 |
| 49 | MP0002006_tumorigenesis | 1.37468804 |
| 50 | MP0010307_abnormal_tumor_latency | 1.33406461 |
| 51 | MP0001851_eye_inflammation | 1.29053036 |
| 52 | MP0005365_abnormal_bile_salt | 1.27109183 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.21995442 |
| 54 | MP0002398_abnormal_bone_marrow | 1.20809285 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.18369554 |
| 56 | MP0005164_abnormal_response_to | 1.17200736 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.16283531 |
| 58 | MP0002933_joint_inflammation | 1.14091217 |
| 59 | MP0000858_altered_metastatic_potential | 1.13882013 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.12901742 |
| 61 | MP0002429_abnormal_blood_cell | 1.11118973 |
| 62 | MP0002090_abnormal_vision | 1.07799583 |
| 63 | MP0003279_aneurysm | 1.07417595 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.05506525 |
| 65 | MP0008260_abnormal_autophagy | 1.00271954 |
| 66 | MP0002722_abnormal_immune_system | 0.98267469 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 0.97486128 |
| 68 | MP0005390_skeleton_phenotype | 0.96450163 |
| 69 | MP0003329_amyloid_beta_deposits | 0.93794952 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 0.92351528 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.91530438 |
| 72 | MP0009763_increased_sensitivity_to | 0.88205851 |
| 73 | MP0003186_abnormal_redox_activity | 0.87493316 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.86905658 |
| 75 | MP0000371_diluted_coat_color | 0.85759087 |
| 76 | MP0009278_abnormal_bone_marrow | 0.83913759 |
| 77 | MP0002254_reproductive_system_inflammat | 0.83309235 |
| 78 | MP0000249_abnormal_blood_vessel | 0.82478060 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.81042037 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.81042037 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.78512267 |
| 82 | MP0001849_ear_inflammation | 0.77025767 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.76470906 |
| 84 | MP0005451_abnormal_body_composition | 0.74861318 |
| 85 | MP0004019_abnormal_vitamin_homeostasis | 0.74443330 |
| 86 | MP0006054_spinal_hemorrhage | 0.74223557 |
| 87 | MP0008874_decreased_physiological_sensi | 0.73183658 |
| 88 | MP0005647_abnormal_sex_gland | 0.72656923 |
| 89 | MP0000920_abnormal_myelination | 0.70145031 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.69393133 |
| 91 | MP0003828_pulmonary_edema | 0.69041253 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.68820915 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.68243910 |
| 94 | MP0003795_abnormal_bone_structure | 0.68044583 |
| 95 | MP0004883_abnormal_blood_vessel | 0.67631952 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.67486584 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.67215135 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.64738687 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.64589614 |
| 100 | MP0001501_abnormal_sleep_pattern | 0.63268903 |
| 101 | MP0005197_abnormal_uvea_morphology | 0.62445251 |
| 102 | MP0005023_abnormal_wound_healing | 0.61943496 |
| 103 | MP0001958_emphysema | 0.61194509 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.60454254 |
| 105 | MP0003045_fibrosis | 0.59733499 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.58535052 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.57513699 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.55989594 |
| 109 | MP0003091_abnormal_cell_migration | 0.55088666 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.54855989 |
| 111 | MP0003705_abnormal_hypodermis_morpholog | 0.51764414 |
| 112 | MP0003634_abnormal_glial_cell | 0.50658508 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.50472888 |
| 114 | MP0003195_calcinosis | 0.50378865 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.50174586 |
| 116 | MP0001663_abnormal_digestive_system | 0.48100428 |
| 117 | MP0008004_abnormal_stomach_pH | 0.47598640 |
| 118 | MP0005165_increased_susceptibility_to | 0.47304002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.11465727 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 6.62961676 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.44892542 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.39522472 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 6.22059174 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.53571098 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.15897602 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.96861531 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.96861531 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.96861531 |
| 11 | Chronic otitis media (HP:0000389) | 4.83352560 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.67224351 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.64631496 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.50678461 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.37865932 |
| 16 | Loss of speech (HP:0002371) | 4.32989949 |
| 17 | Obstructive lung disease (HP:0006536) | 4.06532228 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.06532228 |
| 19 | Recurrent skin infections (HP:0001581) | 4.04270886 |
| 20 | Gingivitis (HP:0000230) | 3.95341208 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.95250497 |
| 22 | Mutism (HP:0002300) | 3.91481942 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.57026011 |
| 24 | Stomatitis (HP:0010280) | 3.43741985 |
| 25 | Myositis (HP:0100614) | 3.40072099 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.34725825 |
| 27 | Basal ganglia calcification (HP:0002135) | 3.34510594 |
| 28 | Nasal polyposis (HP:0100582) | 3.33744755 |
| 29 | Neurofibrillary tangles (HP:0002185) | 3.31350393 |
| 30 | Axonal loss (HP:0003447) | 3.22949198 |
| 31 | Recurrent viral infections (HP:0004429) | 3.14342863 |
| 32 | Mucopolysacchariduria (HP:0008155) | 3.13194315 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.13194315 |
| 34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.12865171 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 3.10954526 |
| 36 | Hepatosplenomegaly (HP:0001433) | 3.09113852 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 3.09090054 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.06374352 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.06374352 |
| 40 | Orchitis (HP:0100796) | 3.05516550 |
| 41 | Disinhibition (HP:0000734) | 2.98301369 |
| 42 | Vasculitis (HP:0002633) | 2.94978014 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.94579311 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.94579311 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.94579311 |
| 46 | Metaphyseal irregularity (HP:0003025) | 2.90249350 |
| 47 | Myocardial infarction (HP:0001658) | 2.85792937 |
| 48 | Upper motor neuron abnormality (HP:0002127) | 2.79969718 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.79076730 |
| 50 | Glomerulonephritis (HP:0000099) | 2.78506928 |
| 51 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.76894172 |
| 52 | Periodontitis (HP:0000704) | 2.74559584 |
| 53 | Cellulitis (HP:0100658) | 2.73853166 |
| 54 | Increased IgM level (HP:0003496) | 2.68558265 |
| 55 | Urticaria (HP:0001025) | 2.65327463 |
| 56 | Poor head control (HP:0002421) | 2.64979405 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.59538992 |
| 58 | Optic neuritis (HP:0100653) | 2.57541565 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.57541565 |
| 60 | Tetraparesis (HP:0002273) | 2.56886703 |
| 61 | Recurrent bronchitis (HP:0002837) | 2.51985656 |
| 62 | Malnutrition (HP:0004395) | 2.51596877 |
| 63 | Nuclear cataract (HP:0100018) | 2.47129255 |
| 64 | Premature loss of primary teeth (HP:0006323) | 2.46074047 |
| 65 | Nephritis (HP:0000123) | 2.45408986 |
| 66 | Osteomyelitis (HP:0002754) | 2.45181077 |
| 67 | Emphysema (HP:0002097) | 2.42582914 |
| 68 | Thick nail (HP:0001805) | 2.42349169 |
| 69 | Pustule (HP:0200039) | 2.40029129 |
| 70 | Chronic sinusitis (HP:0011109) | 2.38534602 |
| 71 | Cerebral inclusion bodies (HP:0100314) | 2.34503679 |
| 72 | Protuberant abdomen (HP:0001538) | 2.32761198 |
| 73 | Progressive visual loss (HP:0000529) | 2.32599176 |
| 74 | Bone pain (HP:0002653) | 2.32075049 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.29452707 |
| 76 | Meningitis (HP:0001287) | 2.29182843 |
| 77 | Recurrent pneumonia (HP:0006532) | 2.28201693 |
| 78 | Prostate neoplasm (HP:0100787) | 2.27345809 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.24777994 |
| 80 | Hematochezia (HP:0002573) | 2.24390495 |
| 81 | Progressive neurologic deterioration (HP:0002344) | 2.24316684 |
| 82 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.22828875 |
| 83 | Colitis (HP:0002583) | 2.22353336 |
| 84 | Retinal atrophy (HP:0001105) | 2.21908813 |
| 85 | Inappropriate behavior (HP:0000719) | 2.18249016 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17653822 |
| 87 | Abnormality of the periventricular white matter (HP:0002518) | 2.17435410 |
| 88 | Gingival bleeding (HP:0000225) | 2.16618813 |
| 89 | Petechiae (HP:0000967) | 2.15717267 |
| 90 | Thoracic kyphosis (HP:0002942) | 2.13027030 |
| 91 | Leukocytosis (HP:0001974) | 2.12460005 |
| 92 | Abnormality of complement system (HP:0005339) | 2.10199932 |
| 93 | Dementia (HP:0000726) | 2.10015452 |
| 94 | Agnosia (HP:0010524) | 2.09697440 |
| 95 | Diminished motivation (HP:0000745) | 2.09088059 |
| 96 | Pathologic fracture (HP:0002756) | 2.07384022 |
| 97 | Conjunctival telangiectasia (HP:0000524) | 2.06917776 |
| 98 | Purpura (HP:0000979) | 2.06539880 |
| 99 | Joint hemorrhage (HP:0005261) | 2.05143360 |
| 100 | Amyloidosis (HP:0011034) | 2.04490446 |
| 101 | Personality changes (HP:0000751) | 2.04009061 |
| 102 | Hemoptysis (HP:0002105) | 2.02573659 |
| 103 | Apathy (HP:0000741) | 1.98826525 |
| 104 | Xanthomatosis (HP:0000991) | 1.98781825 |
| 105 | Restrictive lung disease (HP:0002091) | 1.95281383 |
| 106 | Cardiomegaly (HP:0001640) | 1.93115075 |
| 107 | Esophageal varix (HP:0002040) | 1.92221324 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.92093982 |
| 109 | Vertebral compression fractures (HP:0002953) | 1.91748295 |
| 110 | Nausea (HP:0002018) | 1.91381194 |
| 111 | Thin bony cortex (HP:0002753) | 1.90233228 |
| 112 | Arterial thrombosis (HP:0004420) | 1.87094066 |
| 113 | J-shaped sella turcica (HP:0002680) | 1.85705268 |
| 114 | Prolonged neonatal jaundice (HP:0006579) | 1.84688179 |
| 115 | Porencephaly (HP:0002132) | 1.84669642 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 1.84565977 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84565977 |
| 118 | Supranuclear gaze palsy (HP:0000605) | 1.82312047 |
| 119 | Peripheral demyelination (HP:0011096) | 1.82144674 |
| 120 | Abnormality of the pericardium (HP:0001697) | 1.81556386 |
| 121 | Inflammation of the large intestine (HP:0002037) | 1.81201864 |
| 122 | Complement deficiency (HP:0004431) | 1.81007054 |
| 123 | Increased serum ferritin (HP:0003281) | 1.80153155 |
| 124 | Skin ulcer (HP:0200042) | 1.79870787 |
| 125 | Asymmetric septal hypertrophy (HP:0001670) | 1.79336901 |
| 126 | Global brain atrophy (HP:0002283) | 1.75964308 |
| 127 | Increased CSF protein (HP:0002922) | 1.75723596 |
| 128 | T lymphocytopenia (HP:0005403) | 1.74476770 |
| 129 | Spondylolisthesis (HP:0003302) | 1.72896171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 4.72575392 |
| 2 | BLK | 4.49425816 |
| 3 | TBK1 | 4.21388410 |
| 4 | KIT | 3.60637354 |
| 5 | RIPK4 | 3.52648314 |
| 6 | TYK2 | 3.49380276 |
| 7 | MAP3K14 | 3.27537330 |
| 8 | ERN1 | 3.04901767 |
| 9 | IRAK3 | 2.94072519 |
| 10 | IKBKE | 2.92954165 |
| 11 | IRAK4 | 2.55732742 |
| 12 | MAP4K1 | 2.35936417 |
| 13 | DDR2 | 2.15070888 |
| 14 | JAK1 | 2.13299455 |
| 15 | JAK3 | 2.11429247 |
| 16 | IKBKB | 1.97352148 |
| 17 | PRPF4B | 1.83054286 |
| 18 | CAMKK2 | 1.79406575 |
| 19 | ACVR1B | 1.75761617 |
| 20 | FGR | 1.74845551 |
| 21 | TXK | 1.74593634 |
| 22 | CSF1R | 1.71312660 |
| 23 | FGFR4 | 1.70366792 |
| 24 | CSK | 1.69150950 |
| 25 | CDC42BPA | 1.65528358 |
| 26 | TAOK3 | 1.63538685 |
| 27 | SYK | 1.58894264 |
| 28 | BMX | 1.54203235 |
| 29 | MAP3K13 | 1.48097103 |
| 30 | NME2 | 1.47956128 |
| 31 | NEK9 | 1.46434989 |
| 32 | MATK | 1.45937763 |
| 33 | ABL2 | 1.45197193 |
| 34 | FES | 1.42466956 |
| 35 | TAOK2 | 1.41173764 |
| 36 | TGFBR2 | 1.40966423 |
| 37 | ZAP70 | 1.35466337 |
| 38 | EPHB1 | 1.29693686 |
| 39 | HCK | 1.29476185 |
| 40 | TESK2 | 1.28214356 |
| 41 | RPS6KA4 | 1.26778799 |
| 42 | PIM2 | 1.22613661 |
| 43 | LYN | 1.21600841 |
| 44 | TAOK1 | 1.20132418 |
| 45 | PDK2 | 1.11920465 |
| 46 | LCK | 1.08938701 |
| 47 | JAK2 | 1.03862698 |
| 48 | LIMK1 | 1.00219382 |
| 49 | FGFR3 | 0.98715468 |
| 50 | RIPK1 | 0.96580604 |
| 51 | CHUK | 0.91671667 |
| 52 | MOS | 0.91334471 |
| 53 | CAMK1G | 0.87220370 |
| 54 | RPS6KA2 | 0.82417794 |
| 55 | ARAF | 0.79833461 |
| 56 | GRK7 | 0.78613984 |
| 57 | BTK | 0.78278075 |
| 58 | TRPM7 | 0.76347988 |
| 59 | EGFR | 0.75185302 |
| 60 | BMPR2 | 0.74229910 |
| 61 | TRIB3 | 0.73026662 |
| 62 | MST1R | 0.72856454 |
| 63 | TGFBR1 | 0.72463866 |
| 64 | ERBB3 | 0.71314535 |
| 65 | ABL1 | 0.71270719 |
| 66 | RPS6KL1 | 0.68592461 |
| 67 | RPS6KC1 | 0.68592461 |
| 68 | PRKCD | 0.68547325 |
| 69 | STK4 | 0.62271160 |
| 70 | PIM1 | 0.61842970 |
| 71 | DAPK2 | 0.58586852 |
| 72 | MAP3K9 | 0.58070376 |
| 73 | MAPK12 | 0.56460930 |
| 74 | ITK | 0.56405365 |
| 75 | EIF2AK2 | 0.56351467 |
| 76 | EPHA3 | 0.53830866 |
| 77 | MAP2K6 | 0.53228777 |
| 78 | MARK3 | 0.52431692 |
| 79 | TTN | 0.52023451 |
| 80 | PTK6 | 0.49915241 |
| 81 | EPHB2 | 0.49615311 |
| 82 | PRKCH | 0.49410713 |
| 83 | GRK1 | 0.47807087 |
| 84 | MAPK7 | 0.46448299 |
| 85 | PDGFRB | 0.46278574 |
| 86 | MAP2K3 | 0.44960037 |
| 87 | STK10 | 0.44623411 |
| 88 | ADRBK2 | 0.44277762 |
| 89 | MST4 | 0.43592790 |
| 90 | TEC | 0.42543468 |
| 91 | KDR | 0.41611484 |
| 92 | PDGFRA | 0.40644056 |
| 93 | FYN | 0.40471616 |
| 94 | MAP3K1 | 0.40330924 |
| 95 | MAP3K8 | 0.40058502 |
| 96 | TNK2 | 0.39408162 |
| 97 | MAP3K5 | 0.38386977 |
| 98 | IRAK2 | 0.38112189 |
| 99 | LRRK2 | 0.37365628 |
| 100 | PDPK1 | 0.36487294 |
| 101 | PAK4 | 0.35793755 |
| 102 | TESK1 | 0.33854941 |
| 103 | CDK6 | 0.33685788 |
| 104 | TYRO3 | 0.32734359 |
| 105 | KSR2 | 0.32731551 |
| 106 | PDK1 | 0.31272162 |
| 107 | DAPK3 | 0.30701962 |
| 108 | PRKCQ | 0.30144226 |
| 109 | MAP3K3 | 0.29224230 |
| 110 | MAP3K6 | 0.28779979 |
| 111 | YES1 | 0.28116693 |
| 112 | SRC | 0.26062842 |
| 113 | CAMKK1 | 0.25848568 |
| 114 | IGF1R | 0.24249258 |
| 115 | SIK3 | 0.23756396 |
| 116 | MAPKAPK2 | 0.22896463 |
| 117 | RPS6KA5 | 0.20891689 |
| 118 | CAMK1D | 0.19192033 |
| 119 | INSR | 0.17737650 |
| 120 | PRKG2 | 0.17515049 |
| 121 | RPS6KA6 | 0.17510511 |
| 122 | IRAK1 | 0.16724682 |
| 123 | ALK | 0.16380721 |
| 124 | CLK1 | 0.16180602 |
| 125 | ERBB4 | 0.16002914 |
| 126 | MAP3K11 | 0.15092825 |
| 127 | MAPK4 | 0.14826067 |
| 128 | GSK3A | 0.13886397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.52788118 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.38449845 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.98451063 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.97244350 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.57813211 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.50036913 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.49045513 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.48478241 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44908706 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31253209 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.26765665 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.25330678 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.18648965 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 2.17076815 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15874354 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13054541 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.04968620 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.91118304 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.82945513 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.72747818 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72441006 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.72127526 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69404433 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69245298 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.68298427 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.65790727 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64877880 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57620326 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53110886 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49505899 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48870785 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44243958 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.42790371 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37648234 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37323895 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33668659 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.30154135 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.28846237 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25145027 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24874116 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22007676 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21293063 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19591510 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18379599 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16681821 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.16339211 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.14486115 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08920404 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00756247 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.97990170 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.96334010 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91223118 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89573147 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.83756802 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81207435 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80834210 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77452809 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.75155953 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.70930632 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67567458 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66413185 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65898906 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62069544 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61973937 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60361330 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60221883 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60099501 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57306911 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.55879193 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55298352 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53798058 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52261811 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51622060 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50600241 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48508676 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47544833 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46917542 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44999109 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44421113 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43075764 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42631076 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41497947 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38851335 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36111216 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35241091 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34738575 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34435913 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34057862 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34032027 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31759375 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31238664 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30059634 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.29483186 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.28551712 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27770341 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27098444 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26362762 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25347295 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24080230 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23903030 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23465671 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22702692 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22079216 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21066044 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20997422 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20840572 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20455238 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19684746 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19333483 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19054625 |
| 111 | Proteasome_Homo sapiens_hsa03050 | 0.18907802 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17516284 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.17479552 |
| 114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17406980 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16115387 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.13507794 |

